2 Day Virtual Variations to Marketing Authorisations Training Course
January 31, 2024 04:47 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Variations to Marketing Authorisations Training Course" conference has been added to ResearchAndMarkets.com's offering. It is a key post-marketing...
Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India for Acute Cerebral Ischemic Stroke Patients
May 31, 2023 09:19 ET
|
Pharmazz, Inc.
The proportion of acute cerebral ischemic stroke patients with the mRS of 0-2 on day 90 post-randomization was statistically significant (p=0.002) Sovateltide is a first-in-class drug that...
Variations to Marketing Authorisations Training Course: Optimising Regulatory Procedures to Achieve Faster Approval
May 02, 2023 08:03 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Variations to Marketing Authorisations Training Course" conference has been added to ResearchAndMarkets.com's offering. It is a key post-marketing...
OWLT LOSS ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Owlet, Inc. Investors with Losses to Secure Counsel Before Important January 18 Deadline in Securities Class Action – OWLT
December 28, 2021 18:15 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 28, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds: (a) purchasers of the securities of Owlet, Inc. (NYSE: OWLT) between March 31, 2021 and...
Global Orphan Drugs Market Report 2021-2026 Featuring Market Leaders - AbbVie, Eli Lilly, Johnson & Johnson, Merck & Co., Pfizer and Sanofi-Aventis
August 06, 2021 04:53 ET
|
Research and Markets
Dublin, Aug. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Markets for Orphan Drugs" report has been added to ResearchAndMarkets.com's offering. The Global Orphan Drug Market is Set to Grow to $191...
Global Rare Diseases Drug Development, Clinical Trials and the Regulatory Landscape Report 2021 with Analysis of Trends and Characteristics of Clinical Trials from 1999-2018
January 12, 2021 09:28 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Drug Development in Rare Diseases: Focus on Clinical Trials and the Regulatory Landscape" report has been added to ResearchAndMarkets.com's offering....
Telix Pharmaceuticals submits European marketing authorisation application for prostate cancer imaging product
April 30, 2020 20:14 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, May 01, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has submitted a marketing...
The European Medicines Agency Accepts the Regulatory Submission for Lumoxiti in Relapsed or Refractory Hairy Cell Leukemia
January 02, 2020 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the European Medicines...
The Spanish Agency of Medicines and Medical Devices Grants Marketing Authorization of RIZAPORT®
October 31, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 31, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announced that its commercialization partner for...